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PET Center, Groningen University Hospital
P.O. Box 30.001, 9700 RB Groningen, The Netherlands
(Reeived August 5, 1998)
Positron Emission Tomography (PET) is a method for determining bio-
hemial and physiologial proesses in vivo in a quantitative way by using








F and by measuring the annihilation radiation using a
oinidene tehnique. This inludes also the measurement of the pharma-
okinetis of labelled drugs and the measurement of the eets of drugs on
metabolism. Also deviations of normal metabolism an be measured and
insight in biologial proesses responsible for diseases an be obtained.
PACS numbers: 87.59.Vb
1. General overview
The idea of in vivo measurement of biologial and/or biohemial pro-
esses was already envisaged in the 1930's when the rst artiially produed
radionulides, whih deay under emission of externally detetable radiation,
of the biologial important elements arbon, nitrogen and oxygen were dis-
overed with help of the then reently developed ylotron. These radionu-
lides deay by pure positron emission and the annihilation of positron and
eletron results in two 511 keV -quanta under a relative angle of 180
Æ
whih
are then measured in oinidene. This idea of PET ould only be realized
when the inorgani sintillation detetors for the detetion of -radiation,
the eletronis for oinidene measurements and the omputer apaity for
image reonstrution beame available. For this reason Positron Emission
Tomography is a rather reent development in funtional in vivo imaging.
PET employs mainly short lived positron emitting radiopharmaeuti-
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= 110 min). Car-
bon, oxygen, nitrogen and hydrogen are the elements of life and the building
stones of nearly every moleule of biologial importane. However, hydrogen
has no radioative isotope deaying with emission of radiation whih an be
deteted outside the human body. For this reason a uorine isotope is often
used as a replaement for a hydrogen atom in a moleule. Due to these
short half lives the radionulides have to be produed in house, preferably
with a small, dediated ylotron. Sine the hemial form of the produed
radionulides an only be simple, input from organi and radiohemistry
is essential for synthesis of the desired omplex moleule [1℄. Input from
pharmay is required for the nal formulation and pharmaokineti stud-
ies and medial input is evident and required for appliation. Longer lived
positron emitting radionulides are sometimes ommerially available or ob-
tainable from researh failities with larger aelerators. Some examples of













= 4:2 d). Sometimes also positron emitting


















= 288 d). Although all these radionulides are used, the isotopes of
the biologial most important elements reeive most attention.
At the moment small dediated ylotrons are a ommerially available
produt. These aelerators are one or two partile mahines with xed
energies. At the moment mostly negative-ion mahine are being installed
beause of their relative simple extration system and high extration e-
ieny. They are installed omplete with the targetry for making the four
above mentioned short lived radionulides in Curie amounts. Also the hem-





























, are also available from the
ylotron manufaturer. These produts beome available via dediated,
automated systems or via a programmable roboti system. Other radio-
pharmaeutials have to be set up individually in eah PET enter.
The state of the art positron amera is a omplex radiation detetion
tehnology produt ombined with a relative large omputing power for data
aquisition and image reonstrution [2℄. The basi detetor in a modern
PET amera is a BGO detetor blok divided in 8  8 subdetetors read
out by 4 photomultiplier tubes (PMT). By adding and subtrating the indi-
vidual signals of the PMT's the sintillating subdetetor in the BGO blok
an be identied. Around 70 bloks will form a ring and 4 of these rings
an be added to get an axial eld of view of approximately 1516 m. In
this way 63 planes are imaged simultaneously with a spatial resolution of
45 mm FWHM. The septa between the adjaent subdetetor rings an also
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Fig. 1. Whole-body PET-san with FDG shown at two levels
be retrated reating a muh higher sensitivity in this 3-D mode at the
ost of a larger satter fration. With the present generation of positron
amera's the singles ount rates that an be managed are in the order of
over 50,000,000 ounts per seond resulting in oinidene ount rates of
over 500,000 per seond. Hardware and software for data aquisition, image
reonstrution and for image manipulation is available. Positron ameras
are able to measure the radioativity in absolute terms, Bq/pixel, whih is
an unique feature. This is possible beause the oinidene tehnique al-
lows for the orretion of the attenuation of radiation inside the body of the
individual patient. This orretion is aomplished by making an individ-
ual transmission image with an external positron emitting soure. This
individual transmission image an also be used to orret for sattered ra-
diation present in the image after a 3D-aquisition. This external soure
is built into the amera and an be extended from its well shielded storage
box during the operation of the positron amera. To translate the mea-
sured radioativity distribution into funtional or physiologial parameters
ompartimental models have been developed for radiopharmaeutials with
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known metabolite proles. Although only a few measurable quantities, i.e.
tissue and plasma onentration (the latter by taking blood samples), are
available, it is still possible to alulate e.g. the gluose onsumption by
employing a dynami data aquisition protool in ombination with a om-
partimental model [3℄. It is also possible to make a whole body san by
translating the patient through the PET amera. By projetion the trans-
verse setion images a whole body overview an be made. An example is
shown in Fig. 1 where in an onologial patient the gluose onsumption
is shown. A normal, high onsumption in the brain and the heart (right
image), a large tumor on the left image and two smaller on the right image
are seen by their abnormal high gluose metabolism.
A PET enter is the ombined relevant knowledge of hemistry, mediine,
pharmay and physis and a PET enter is staed by all these disiplines in
a good oopering team.
2. Possibilities of PET in researh and patient are
The linial appliations of PET are in the elds of ardiology, neurology
and onology. In the ardiology the measurement of the myoardial blood
under rest and stress onditions with
13





F-uorodeoxygluose) is a standard examination
in order to disriminate between isohemi and infarted tissue. In the neu-
rology the erebral blood ow and/or the energy onsumption of the brain
is the standard examination. In the onology PET is used for the detetion
of tumors and to measure the eet of therapy on the tumor metabolism.
In Table I dierent radiopharmaeutials for ardia studies are summa-
rized.
13
N-ammonia is used for the measurement of the myoardial blood
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Positron Emission Tomography 1623
ow. To study the viability of the heart it is used in ombination with
18
FDG. The ombination of ammonia rest, ammonia stress and metabolism
study deliver a muh too large number of images to evaluate individually.
For this reason software to re-orient the images perpendiular to the long
axis of the heart followed by a translation of the data into quantitative pa-
rameters of blood ow and gluose onsumption per heart region has been
developed. Blood ow and metabolism are than visualized per examination
in a so alled polar map. It also possible to use the eletro-ardia signals to
make a gated ardia study. From this data it is possible to generate images
of the beating heart and if from these images the wall of the left ventrile
an be deteted, the wall motion an be quantied.
In Table II dierent radiopharmaeutials for neurosiene studies are
summarized. The linial and researh programs in Groningen are direted
to gluose metabolism (
18
FDG), protein synthesis rate (PSR) with
11
C-
tyrosine [4℄ and blood ow with H
2
15
O [5℄. The improvement in resolution
an be seen in Fig. 2 where the gluose metabolism of the brain is shown
for the dierent generations of PET sanners. For onologial studies both
Fig. 2. The gluose onsumption in the human brain as measured with FDG on the
dierent generations of PET ring systems (Courtesy of CTI PET Systems, In.).
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18
FDG as well as L-[1
11
C℄tyrosine are available. Software for the transla-
tion of measured radioativity into gluose-onsumption (
18
FDG) and pro-
tein synthesis rate of
11
C-tyrosine have been developed. The D
2
reeptor in




C-ralopride and is of
importane in the ase of Parkinson's disease. Measurement of the regional
erebral blood ow (rCBF) with H
2
15
O is of great importane to disover
the funtional anatomy in elds like ognitive neurosiene, linguistis, se-
letive attention and to measure the eet of drugs on the rCBF in dierent
ategories of patients.
TABLE II
Measurements and radiopharmaeutials of importane for neurosiene
Measurements Radiopharmaeutial




































In Table III dierent radiopharmaeutials for onologial studies are
summarized. For the study of tumor metabolism
18
FDG is often used but
other possibilities in the form of amino aids do exist. Also the eet of
therapy on the tumor metabolism an be quantied by measuring before and
after therapy. By performing the seond study already during the therapy
also a prognosti statement an be made. For onologial brain studies the
use of an amino aid an be favourable due to the better signal to noise
ratio whih an be obtained with respet to the gluose metabolism study.
It is also possible to generate wholebody images by projeting a number
of onseutive transverse images into a planar image.
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TABLE III























The ylotron as available now for PET enters is dierent from the older
mahines used in the eld of nulear physis not only beause of the limited
number of partiles and xed energy but also beause of the inorporation
of the targetry for the most important radionulides. Automation and om-
puter ontrol is integrated into the design. Not only the beam quality but
also the beam urrent is a major parameter beause the urrent determines
the prodution apaity. Beam quality is not that ruial for radionulide
prodution and in fat the beam power density (W/m
2
) should not be too
high. For the daytoday operation no separate operating team is required,
the ylotron an be operated by the tehnial hemial sta. The present
developments tend into a few diretions, but redution in osts by e.g. a
redution in maximum beam energy is a general goal for the marketing of
ylotrons for linial PET-enters. Redution in maximum energy results
in a smaller mahine and onsequently a redution in osts is possible. Lower
energy leads also to less penetrating partiles and onsequently to thinner
targets with a lower yield. Consequently the target tehnology beomes
more diult and more ritial by this redution in beam energy beause
the beam urrent has to be inreased to keep up in prodution apaity.
The hange to a superonduting magnet dereases the weight with a large
fator. Sine the prodution apaity should stay the same the thikness of
the shielding is also the same but the overall size o the vault, and so the
osts, an be dereased again. Some ylotron manufaturers also provide
loal movable shielding of onrete and lead, tting tightly around the ael-
erator, resulting in lower total mass of the shielding. Also developments in
linear aelerators (linas) and in Radio Frequeny Quadrupole aelerators
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(RFQ's) for the prodution espeially of the four PET radionulides, are
taking plae. However, it still has to be shown that this, may be ost ee-
tive solution, is a ompetitor in radionulide yields with the now operating
17 MeV proton ylotrons.
The radiation detetors used in positron ameras at the moment are
made of BGO in most ases but also NaI and BaF
2
has been used or still is
in use. Although BGO and BaF
2
have a high stopping power for 511 keV
and a number of other favourable properties, the light yield of NaI is also
favourable. The ideal detetor for a positron amera should have a time
resolution of approximately 10 ps and this ombined with other properties
like high stopping power, high Z, non hygrosopi et. This extreme fast
timing would allow for the measurement of the plae of annihilation within
a few millimetres by means of the time of ight (TOF) measurement. With
the present detetors only the line on whih the annihilation took plae is
being determined. The ltered bak projetion reonstrution tehnique in
ombination with blok struture of the detetors makes a spatial resolution
of 45 mm FWHM standard. Reently LSO (lutetium-orthosiliate) has
been disovered as a sintillator [6℄. LSO ombines the good properties of
BGO with high light yield (75% of the yield of NaI) and is also rather fast (40
ns). A disadvantage is the presene of natural radioative isotope of lutetium
but, sine a oinidene tehnique is employed, this will not inuene the
image formation. The higher light yield will improve the energy resolution
and by this derease the satter fration. At the moment small LSO PET-
sanners are being built for small animals (rats and mie) and a spatial
resolution of 2 mm FWHM has been ahieved in these systems. In the
(near) future whole-body systems with this spatial resolution will beome
available.
The fundamental limit in the spatial resolution is of ourse the range
of the positron itself. At the mean positron energy, 40 % of the maximum
energy, the range of the positron varies from 1.1 mm for
11
C via 2.5 mm
for
15
O to 5.9 mm for
82
Rb. At the moment interplane septa are used to
limit the opening angle of eah individual plane. This redution of opening
angle is neessary to keep the amount of sattered 511 keV -quanta within
reasonable bounds. By removing these septa the eieny of the whole
system inreases with a large fator but the fration of sattered radiation
will also inrease. This is due to the rather bad energy resolution, 25% at 511
keV, of the BGO blok detetors used. Nevertheless a lot of eorts has been
invested in the development of systems without septa and in the development
of orretion algorithms for satter, yielding a three dimensional imaging
system [7℄.
The fat that the annihilation of positron and eletron does not take plae
at zero momentum is proven by the fat that there is a nite angular width
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of 0:5
Æ
FWHM in the angular distribution about the mean angle of 180
Æ
.
With a detetor ring diameter of roughly 80 m and an improving spatial
resolution this parameter is beoming more important as a limitation in the
spatial resolution.
4. PET and other imaging modalities
The most ommon imaging tehnique in mediine uses X-rays. In its
most simple form a density projetion is generated by holding the subjet
of interest between the X-ray tube and a photographi plate. The advaned
form an be found in a CT-sanner in whih a rotating X-ray soure and
detetors make a transverse setion image. Again sort of a density map is
generated although extration of the exat density will not be possible, and is
also not neessary for diagnosti use, due to the broad energy spetrum of the
generated X-rays. Due to the large dierene in density between bones and
tissue the bones an be visualized perfetly while small dierenes in tissue
density will be more diult to visualize. The use of ontrast agents, like
uids with high densities and high Z-omponents, an hange the dierene
in density and by this the interpretation of the images dramatially.
The Nulear Magneti Resonane (NMR) tehnique is in use to visualize
the protons (bound to water) in the human body. Homogeneous magneti
elds up to 2 T are in use in medial NMR sanners, nowadays abbreviated to
MRI (Magneti Resonane Imaging). In order to have a short imaging time,
gradient elds with frequeny deoding are used. The strength of the NMR
signal is proportional to the dierene in population of the spinup and spin
down state. Under normal onditions at room temperature the ratio between
spinup and spindown is rather lose to unity. The NMR tehnique is a
rather insensitive tehnique [8℄ for this reason but whih is suessful beause
of the high water onentration in the human body. Also paramagneti
ontrast agents like Gd-DTPA are used to inrease the ontrast. Both, the
X-ray and the MRI tehnique, supply anatomial information.
With NMR also information on the struture of moleules an be ob-
tained, as is done in the hemistry. This is also possible in the human body
but limited to the brain and to moleular strutures whih have a onen-
tration of 0.1 mM or more as a rule of the thumb. The limitation to brain
tissue is beause the signals from water and fatty tissues have to be sup-
pressed and these onentrations are rather low in the brain in ontrast to
e.g. the thorax.
By using radionulides bound to dierent moleular strutures funtional
emission imaging beame available in the 1950's. It is funtional imaging
beause the hemial struture and the human metabolism determine the
fate of the moleule in vivo. PET is the ultimate form of nulear mediine.
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Beause the nulear reations for the prodution of positron emitting ra-
dionulides are of the type (p; n) or (p; a) in most ases, the element pro-
dued is dierent from the target element. By this type of reations the
amount produed in weight is extremely low (1 Ci of
11
C has a weight of
1.2 ng) while the amount of radioativity is onsiderable (1 Ci of
11
C an
routinely be made and a patient dose is 10 mCi). This so alled spei
ativity ( MBq/mg) is of importane e.g. for reeptor researh and makes it
possible to all it traer experiments.
Sine the PET method supplies funtional information the ombination
with X-ray and NMR tehniques, CT and MRI, would yield an identiation
of the funtional anatomy. In order to make this ombination the images of
the dierent disiplines should be available in a transparent way and image
resize and re orientation tehniques should be available to math the images
from the dierent modalities. At the moment there are no general appliable
routines available to perform this kind of mathing operations. In a number
of PET enters the ombination of PET , CT and NMR images is subjet
of interest. In some institutions also the omparison and transformation
of PET images to a stereotati brain atlas have been performed [5℄. The
head and brain are the rst struture/organ of hoie to evaluate the multi-
modality mathing for obvious reasons.
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